New Drug Introduction

[NDI] Dose-Dependent Modulation of Swallowing by BAB-02001 in a Preclinical Animal Modelof Swallowing

Peter Belafsky², Benjamin Buller¹, Laura Remesal¹, Dario Doller¹, Sacha Schermerhorn¹ (1. Babylon Biosciences, Inc., San Francisco, CA, USA, 2. Department of Otolaryngology, UC Davis Medical Center, Sacramento, CA, USA)

Password required to view